From Rita Wilson to Teddi Mellencamp, these brave celebrity women have inspired us with their candidness about the realities ...

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a ...

Early circulating tumor DNA (ctDNA) changes predict survival in mismatch repair or microsatellite instability–high (dMMR/MSI-H) metastatic colorectal cancer (mCRC) treated with immune checkpoint ...

Cancer researchers have a multitude of tools to study tumors. Histological staining uses dyes to make different kinds of ...

Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR) in Lisbon, it is worth highlighting ...

GRAND RAPIDS, Mich. — Corewell Health in Grand Rapids is now offering a new, non-invasive therapy to treat liver cancer.

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

New trial data reveals atebimetinib combined with gemcitabine/nab-paclitaxel significantly improves survival rates in ...

Calviri recently published results for its StageOne Plus test, designed to find stage 1 tumors in dogs with impressive ...

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...

Radiation therapy is often seen as a powerful weapon against cancer. But a surprising new study from the University of ...